Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Withdrawal symptoms levels

Nicotine Delivery Systems. For all transdermal nicotine products, the hypothesis is that continuous deflvery of nicotine [34-11-3] ne t trough levels during smoking should alleviate physical nicotine withdrawal symptoms and allow the smoker to concentrate on eliminating the behavioral aspects of addiction. [Pg.230]

Personality variables, state of mind at time of withdrawal, and expectations of severity of symptoms all may affect withdrawal severity (Kleber 1981). One study found that merely providing addicts information about the withdrawal syndrome resulted in lower levels of withdrawal symptoms (Green and Gos-sop 1988). Naloxone rapidly induces a severe withdrawal syndrome, which peaks within 30 minutes and then declines rapidly. Until the antagonist is eliminated, only partial suppression of the withdrawal syndrome is possible, and then only by using very high opioid doses, which may cause respiratory depression when naloxone is metabolized. [Pg.71]

Nervirapine is an HIV drug that is a CYP3A4 inducer in a small sample, nevirapine caused a 50% reduction in methadone blood levels, resulting in complaints of methadone withdrawal symptoms in patients receiving methadone maintenance may need to increase methadone dose in patients who have nevirapine added to their drug regimen. [Pg.534]

Since nicotine has wide ranging effects on the central nervous system it seems likely that pharmacogenomic effects on the development of nicotine dependence will span several neurotransmitter systems. One study found an association between a polymorphism in dopamine /1-hydroxylase and level of tobacco consumption [20]. This enzyme is important in noradrenaline synthesis and it is tempting to speculate that genetically regulated variations in activity might influence susceptibility to nicotine withdrawal symptoms mediated by noradrenergic pathways, but more information is required on the molecular effects of the polymorphism. [Pg.450]

Hurt, R. D., Dale, L. C., Croghan, G. A., Croghan, I. T., Gomez-Dahl, L. C. and Offord, K. P. 1998. Nicotine nasal spray for smoking cessation Pattern of use, side effects, relief of withdrawal symptoms, and cotinine levels. Mayo Clinic Proceedings, ly. 118-125. [Pg.267]

Suppression of heroin self-administration in opioid-dependent volunteers has been found to be greater at doses over lOOmg (Donny et al. 2005), and this relates to the three-level effects of methadone, the implications of which we often have to contend with in our discussions with patients. Basically low doses of methadone will suppress opiate withdrawal symptoms in dependent individuals, and this is what a lot of patients mean when they say that their dose (which may be considered too low by us) holds them. In medium to high levels of methadone there is less craving for opiates, and then at the highest doses there will be full narcotic blockade (Donny et al. 2002), but as already indicated the users themselves may not wish to take such dosages. [Pg.21]

Methadone [P] Decreased serum methadone levels withdrawal symptoms. [Pg.1398]

It is important to distinguish three levels of dependency. The first level 1 call physical dependency. Very roughly, individuals are physically or chemically dependent on some substance if consuming that sub stance has made them prone to suffer withdrawal symptoms— discomfort, agitation, restlessness, illness—when deprived of the substance for a period of time and, usually, to find the ingestion of the substance highly pleasurable. [Pg.12]

Rational consumers who discount future value/ / / tittle will not start to consume much of the good. People who discount future value very little, less than intermediate discounters, might be able to cut down from a high level of consumption (if they find themselves there) if the long-term reduction in welfare matters more to them than the short-term gain (for instance, in relief from withdrawal symptoms). [Pg.39]

GHB is also addictive. Regular, daily use of GHB can cause physical dependency with harsh withdrawal symptoms. At four to six average doses per week, people report finding that they need to increase their dose to get the same level of intoxication. Many subsequently report that they need a little GHB just to feel normal. With very heavy use (one or more doses per day), many people report very serious physical addiction. Stopping cold turkey results in anxiety, inability to sleep, and feeling like the heart is arrhythmic (irregular). [Pg.134]

The short half-life of nicotine contributes to its abuse potential. The initial effects drop off after a few minutes, causing the user to continue self-administering nicotine throughout the day to maintain pleasurable effects and prevent withdrawal symptoms. Studies clearly show that animals will self-administer nicotine intermittently to avoid both very low and very high levels of nicotine. [Pg.367]


See other pages where Withdrawal symptoms levels is mentioned: [Pg.381]    [Pg.19]    [Pg.33]    [Pg.135]    [Pg.316]    [Pg.323]    [Pg.328]    [Pg.328]    [Pg.124]    [Pg.9]    [Pg.93]    [Pg.135]    [Pg.144]    [Pg.183]    [Pg.548]    [Pg.81]    [Pg.114]    [Pg.115]    [Pg.116]    [Pg.196]    [Pg.350]    [Pg.494]    [Pg.39]    [Pg.354]    [Pg.53]    [Pg.67]    [Pg.77]    [Pg.82]    [Pg.102]    [Pg.198]    [Pg.256]    [Pg.484]    [Pg.883]    [Pg.501]    [Pg.1795]    [Pg.502]    [Pg.88]    [Pg.336]    [Pg.115]    [Pg.357]   
See also in sourсe #XX -- [ Pg.144 ]




SEARCH



Withdrawal symptoms

© 2024 chempedia.info